Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Fixed dose combinations – beneficial or harmful?

  • At: 2009 FIP Congress in Istanbul (Turkey)
  • Type: Poster
  • By: DHARMAGADDA, Sreedhar (Manipal College of Pharmaceutical Sciences, Manipal, India)
  • Co-author(s): Ligade, Virendra (Manipal College of Pharmaceutical Sciences, MANIPAL, India)
    Janodia, Manthan (Manipal College of Pharmaceutical Sciences, MANIPAL, India)
    Nayanabhirama, Udupa (Manipal College of Pharmaceutical Sciences, MANIPAL, India)
  • Abstract:

    Fixed dose combinations (FDCs) are solid dosage forms containing more than one active ingredient. There are numerous fixed dose combinations available in the Indian market; some provide benefits to patients while others pose risk. It is the drug manufacturers who had introduced the drug combinations to physicians for financial gains or to sustain..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses